Beyond Billing: Ensemble Links AI-Driven Finance to Patient Care

CINCINNATI, OH – January 12, 2026 – For the second consecutive year, Ensemble Health Partners has secured a top spot in Modern Healthcare’s prestigious Best in Business awards, a recognition that highlights the growing link between sophisticated back-office technology and the front lines of patient care. The award solidifies the company's position as a leader in a field critical to the stability of the entire U.S. healthcare system: revenue cycle management (RCM).

Ensemble, which partners with health systems to manage their complex financial operations from end to end, was honored in the Healthcare Technology category for 2025. The award acknowledges innovators who are not just adapting to rapid industry changes but are actively advancing the healthcare ecosystem. For Ensemble, this recognition underscores a core philosophy: that a financially healthy hospital is better equipped to serve its community.

A Pattern of Industry-Wide Recognition

Modern Healthcare's award is not an isolated event but the latest in a string of accolades that paint a picture of a company dominating the RCM landscape. The Best in Business award is determined by a rigorous evaluation process, judged by a panel of industry experts who assess nominees on five key pillars: Quality, Outcomes, Efficiency, Customer Focus, and Innovation. This comprehensive methodology aims to identify partners who deliver tangible value to healthcare providers.

This consistent validation from industry authorities sets Ensemble apart in a crowded and competitive market. The company has been ranked #1 by KLAS Research for end-to-end revenue cycle outsourcing for four consecutive years, an achievement based directly on feedback from healthcare provider clients. Its score of 95.1 out of 100 in the 2025 KLAS report signals exceptionally high client satisfaction.

Further cementing its leadership status, Ensemble has been named a Leader in both the Everest Group's RCM Operations PEAK Matrix Assessment and the IDC MarketScape for U.S. RCM Service Solutions. These analyst reports evaluate vendors on strategic vision and execution capabilities, placing Ensemble at the forefront of the industry alongside major competitors like R1 RCM and Optum. This pattern of recognition from multiple independent bodies suggests the company's claims of driving significant client results are well-founded.

The $100 Million AI Engine Driving Performance

At the heart of Ensemble’s success is a massive and sustained investment in technology, totaling more than $100 million annually. This capital is funneled into its proprietary intelligence platform, EIQ®, an ecosystem designed to move healthcare finance from fragmented, transactional tasks to a unified, outcome-driven model.

This is not simply about automation; it's about intelligence. The company has deployed over 5,500 distinct AI models that analyze data from more than 25 billion transactions. This vast data lake, exceeding 2,000 terabytes, allows EIQ® to perform predictive analytics, intelligently prioritize work for its nearly 15,000 associates, and execute "zero-touch automation" on routine tasks. This approach aligns with a broader industry shift where AI is no longer a luxury but a necessity for managing the immense complexity of medical billing and reimbursement. The focus is moving from reactively managing claim denials to proactively preventing them.

Ensemble's patented "Next Best Action" technology, for instance, predicts and automates the optimal steps to resolve a claim, ensuring accuracy and speed. Furthermore, a deepening partnership with Microsoft is enabling the company to pioneer the use of generative AI for tasks like drafting personalized and context-aware appeal letters, a process that has historically been manual and time-consuming. This deep integration of AI is designed to minimize errors, reduce administrative waste, and accelerate cash flow for its hospital partners.

Translating Financial Health into Community Well-Being

While the technology is complex, the goal is straightforward: to strengthen the financial foundation of healthcare providers so they can better fulfill their primary mission. This transforms the role of an RCM partner from a mere vendor to a strategic enabler of community health.

“This consecutive recognition as Modern Healthcare’s Best in Business is a testament to our commitment to providing excellent services and partnership to our clients and their patients nationwide,” said Judson Ivy, founder and CEO of Ensemble. “Supporting a high-functioning RCM system doesn’t just end at maximizing financial performance, it unlocks capacity to invest in priorities that include constructing new hospital infrastructure like rehabilitation centers, expanding specialty services and developing sophisticated advanced care units. And this ability to support long term community health needs is what we are most proud of.”

This perspective frames RCM as the unsung hero of healthcare resilience. In an era of shrinking margins, complex regulations, and rising operational costs, many hospitals struggle to remain financially viable. By optimizing the revenue cycle—ensuring that the care provided is accurately documented, billed, and paid for—companies like Ensemble provide the stability necessary for survival and growth. This financial stewardship allows hospital leadership to focus on clinical innovation and patient-facing initiatives rather than being bogged down by administrative and financial challenges.

Charting Dominance Through Growth and Results

Ensemble's strategic focus on technology and partnership has fueled remarkable growth. In 2025 alone, the company welcomed seven new health system partners, expanding its portfolio to manage more than $46 billion in net patient revenue. This figure, which has grown from $32 billion in early 2024, is now equivalent to the revenue of the second-largest health system in the United States, illustrating the immense scale of Ensemble's operations.

The company reports that its proprietary approach consistently delivers a 5% average net revenue improvement for its clients, a significant boost that can translate into tens of millions of dollars for a large health system. While detailed, independently verified case studies are proprietary, the consistent top rankings from client-survey-driven organizations like KLAS provide strong indirect evidence that these results are being realized.

This combination of technological innovation, proven results, and strategic growth has firmly established Ensemble as a dominant force in healthcare finance. By demonstrating a clear line from AI-driven efficiency to enhanced financial stability, the company is making a powerful case that a well-managed revenue cycle is not just good for business—it is essential for the future of patient care.